Combined Open and Endovascular Treatment of Thoracoabdominal Aneurysms and Secondary Expanding Aortic Dissections: Early and Mid-Term Results From a Single-Center Series
Article Outline
Background
We present a review of our experience with combined surgical therapy with endovascular stent repair and conventional revascularization of the supraaortic and/or visceral/renal arteries (hybrid procedure) in the treatment of thoracoabdominal aortic aneurysms and dissections.
Methods
We followed 20 patients (7 women, median age 58.3 years, age range 37-68 years) prospectively. Severe comorbidity was present in 7 patients, 13 patients had previous aortic surgery. The median diameter of the thoracoabdominal aneurysm was 74.4 mm (Crawford I, 1 patient; II, 11; III, 7; V, 1), and 13 patients had previous aortic surgery. After visceral and renal revascularization, three stent grafts were implanted on average. Follow-up examination was every 6 months. The median follow-up was 174.5 days (15-375 days).
Results
The 30-day mortality was 10% and the neurological complication rate was 10% with incomplete paraparesis in 2 patients. Computed tomography scanning revealed six endoleaks in 5 patients (Type Ia, 3 patients; Ib, 1; II, 1; III, 1) and four visceral graft occlusions in 4 patients (right renal artery, 2 patients; left renal artery, 2). Endoleaks (Ia, Ib, and III) were surgically revised. During follow-up, 3 patients died. The remaining patients recovered to full activity. A significant aneurysm shrinkage was found in 5 patients. Two patients developed secondary endoleaks.
Conclusion
Our results show that hybrid procedure might be an alternative to conventional thoracoabdominal repair of the aorta, especially in high-risk patients.
Introduction
The natural course of a thoracoabdominal aneurysm (TAAA) is fatal with a 2-year mortality rate of up to 76%, whereas after surgery this rate decreases to 30%.1, 2 However, open repair of TAAAs is associated with a mortality rate of 20% in National Data Sets3, 4, 5, 6 and 4%-16% at specialized centers.6, 7, 8, 9, 10, 11, 12, 13 Severe complications include paraplegia (1%-15%), acute renal failure (2.3%-12.7%), and severe cardiopulmonary complications (4.4%-33%).5, 6 Increased morbidity is associated with severe pulmonary disease (up to 40%) and renal impairment (up to 30%). Severe renal, cardiac, or pulmonary comorbidity; Crawford extent Type II TAAA; and redo surgery are especially associated with a higher mortality risk and a higher risk for severe complications.5, 11, 14, 15, 16
Due to the significant complication rates for open thoracoabdominal repair, aortic endovascular exclusion combined with debranching techniques of the supra-aortic and the visceral/renal arteries may be an alternative for high-risk patients. The hybrid procedure combines open surgical revascularization of the visceral and renal arteries followed by an endovascular exclusion of the aneurysm. Several groups reported cases and smaller series.17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31. So far, three clinical series with 29, 13, and 6 patients have been published,32 with promising results in terms of mortality and paraplegia rates. Results from a larger series from St. Mary´s Hospital containing 29 patients5 showed no paraplegia and a 30-day mortality rate of up to 13%. This article reviews our experience with urgent and elective hybrid procedures for TAAAs since 2004.
Methods
Patients
Between November 2004 and May 2007, we followed 20 patients prospectively (7 females, median age 58.3 years, age range 37-68 years) who underwent a hybrid procedure to treat TAAA and secondary expanding dissection (SED). Eighteen patients (TAAA, 8 patients; SED, 10) were treated electively, and 2 patients were admitted with contained ruptures (TAAA, 1 patient; SED, 1). Severe comorbidity was present in 7 of 20 patients (35%). 9 patients had previous thoracic aortic surgery, and 8 patients had previous major abdominal surgery, of whom 4 patients had infrarenal aortic replacement (Table I).
Table I. Demographic and anamnestic data for 20 consecutive patients with hybrid procedure
| Patient | Age (years) | Gender | BMI | Symptomatology | HAT | DM | HCH | Smoker | RI | COPD | CAD | ASA | Prev Abd Surg | Prev Thor Surg |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 68 | Male | 24 | Asymptomatic | No | No | Yes | Yes | Yes | Yes | No | 3 | ||
| 2 | 61 | Male | 25.2 | Thoracic pain | Yes | No | Yes | Yes | No | No | Yes | 3 | ||
| 3 | 62 | Male | 29.4 | Back pain | Yes | No | Yes | Yes | No | No | No | 3 | ||
| 4 | 46 | Male | 18.1 | Asymptomatic | Yes | No | No | Yes | No | No | No | 3 | ||
| 5 | 68 | Female | 26.2 | Thoracic/abdominal pain | Yes | No | No | Yes | No | No | No | 3 | ||
| 6 | 66 | Female | 31.6 | Rupture visceral segment | Yes | No | Yes | No | Yes | No | No | 4 | Kidney transplantation | |
| 7 | 52 | Female | 22.1 | Asymptomatic | No | No | No | Yes | No | No | No | 2 | ||
| 8 | 63 | Female | 20.1 | Asymptomatic | No | No | No | Yes | No | No | No | 3 | AV&R | |
| 9 | 37 | Female | 19.2 | Thoracic/abdominal pain | Yes | No | No | No | No | No | No | 3 | IRAAA repair | AV&R |
| 10 | 64 | Male | 19.8 | Asymptomatic | Yes | No | Yes | No | No | Yes | No | 4 | IRAAA repair | AV&R |
| 11 | 43 | Male | 30.7 | Flank pain | Yes | No | No | Yes | No | No | No | 2 | Stomach surgery | |
| 12 | 49 | Male | 22.6 | Asymptomatic | Yes | No | No | Yes | No | No | No | 3 | AV&R | |
| 13 | 57 | Male | 24.4 | Asymptomatic | No | No | Yes | Yes | Yes | No | No | 3 | IRAAA repair | AV&R |
| 14 | 49 | Male | 29 | Asymptomatic | Yes | No | No | Yes | No | No | No | 2 | AV&R Tevar | |
| 15 | 63 | Male | 26 | Asymptomatic | Yes | No | Yes | Yes | No | No | No | 3 | IRAAA repair | Thoracic aortic repair |
| 16 | 67 | Female | 18.7 | Thoracic/abdominal pain | Yes | No | No | Yes | No | No | No | 3 | ||
| 17 | 67 | Male | 30.4 | Asymptomatic | Yes | Yes | Yes | No | No | No | Yes | 3 | Iliac repair | AV&R |
| 18 | 68 | Female | 23.1 | Asymptomatic | No | Yes | No | Yes | No | No | No | 4 | Cholecystectomy | |
| 19 | 58 | Male | 26.5 | Asymptomatic | No | No | Yes | No | No | No | No | 3 | AV&R | |
| 20 | 57 | Male | 32.1 | Rupture descending aorta | Yes | No | Yes | Yes | No | Yes | No | 4 |
| Median age (range) | 62 (37-68) |
| Median BMI (range) | 24.8 (18.1-32.1) |
| Arterial hypertension | 65% |
| Diabetes | 10% |
| Hypercholesterolemia | 50% |
| Smoking | 75% |
| Renal Impairment | 15% |
| COPD | 15% |
| CAD | 10% |
| ASA 2 | 10% |
| ASA 3 | 60% |
| ASA 4 | 10% |
| ASA 5 | 10% |
| Previous thoracic surgery | 40% |
| Previous abdominal surgery | 45% |
The aneurysms were classified according to the modified Crawford classification (Fig. 1).33 We found Crawford Type I in 1, Type II in 11, Type III in 7, and Type V in 1 patient. The median maximum diameter of the aortic aneurysm was 71.5 mm (50-120 mm) (Table 2). Due to the severe comorbidity, previous aortic surgery, and aneurysm morphology, 75% of the patients of this series were of high risk for surgical repair of their TAAA.
Table II. Morphological data on the aneurysms
| Patient | SED/TAAA | Crawford type | Length proximal neck (mm) | Diameter proximal neck (mm) | Maximum diameter of aneurysm (mm) | Length distal neck (mm) | Diameter distal neck (mm) |
|---|---|---|---|---|---|---|---|
| 1 | SED | II | 15 | 25 | 68 | 50 | 20 |
| 2 | TAAA | I | 50 | 34 | 96 | 24 | 30 |
| 3 | TAAA | III | 110 | 32 | 61 | 24 | 24 |
| 4 | TAAA | II | 23 | 29 | 55 | 30 | 24 |
| 5 | SED | III | 70 | 30 | 78 | 0 | 28 |
| 6 | TAAA | II | 60 | 36 | 120 | 30 | 31 |
| 7 | TAAA | III | 80 | 33 | 58 | 50 | 20 |
| 8 | TAAA | II | 170 | 36 | 72 | 30 | 23 |
| 9 | SED | II | 35 | 33 | 71 | 32 | 20 |
| 10 | SED | II | 20 | 34 | 86 | 50 | 20 |
| 11 | SED | III | 50 | 27 | 50 | 30 | 20 |
| 12 | SED | II | 50 | 40 | 78 | 30 | 20 |
| 13 | SED | II | 20 | 40 | 100 | 30 | 20 |
| 14 | SED | III | 50 | 36 | 61 | 30 | 20 |
| 15 | TAAA | V | 50 | 30 | 77 | 30 | 20 |
| 16 | TAAA | III | 50 | 34 | 54 | 30 | 21 |
| 17 | SED | II | 50 | 43 | 92 | 30 | 20 |
| 18 | SED | III | 150 | 32 | 58 | 30 | 30 |
| 19 | TAAA | II | 50 | 42 | 62 | 50 | 23 |
| 20 | SED | II | 36 | 32 | 90 | 30 | 20 |
| Median (range) | 50 (0-170) | 33.5 (25-43) | 71.5 (50-120) | 30 (24-50) | 20 (20-31) |
Planning of the Procedure
All patients underwent contrast-enhanced multislice computed tomography (CT) scanning performed from the carotid bifurcation to the femoral arteries. If a minimal length of the distal or proximal attachment site of 20 mm was not given, proximal attachment site was optimized by proximal debranching and distal attachment by infrarenal aortic replacement. CT scans and CT reconstructions were used for the stent planning. In the proximal and distal attachment sites, an oversizing of 10%-20% was targeted and an overlap of 5-8 cm between two stents was projected. In case of significant tapering of the attachment sites, the procedure was planned in reversed trombone technique.
Surgical Procedures
A supra-aortic debranching prior to the visceral hybrid procedure was necessary in 4 of 20 patients; 3 patients received a bypass from the right common carotid artery to the left subclavian artery with an implantation of the left common carotid artery into the graft and ligation of the proximal left common artery and the left subclavian artery proximal of the vertebral artery. One patient received a bypass from the left common carotid artery to the left subclavian artery in the same manner.
The hybrid procedures were performed with the patient under general anesthesia in the supine position. Cell salvage, transfusion, and rapid infusers were used. A median transabdominal approach was used to provide exposure to the abdominal aorta, the celiac artery, the superior mesenteric artery, and both renal arteries. In 7 patients, the infrarenal aorta was replaced by a Dacron graft to create a distal attachment site. The inflow site for retrograde visceral artery grafting was determined for each patient individually according to previous abdominal aortic surgery and the extent of the thoracoabdominal disease. In case of infrarenal aortic replacement by tube interposition, or if no replacement was necessary (14 patients), the bypass grafts were anastomosed in an end-to-side version to both native common iliac arteries. If the infrarenal aorta (6 patients) and iliac arteries were replaced by a bifurcated infrarenal graft, the visceral bypasses were anastomosed in a side-to-end version to the limbs of the prosthesis. The superior mesenteric artery was revascularized in all patients, and the celiac trunk in 17 patients; in 2 patients, revascularization of the celiac trunk was technically impossible because of severe obesity, and in 1 patient, the celiac trunk was occluded.
Revascularization of the renal arteries was not performed bilaterally in 2 patients (TAAA Crawford I, end-stage renal disease [ESRD]); it was performed on the left side, because 1 patient was nephrectomized and the other patient had a nonfunctioning kidney. After cold perfusion of the kidneys, the right renal artery was revascularized in 18 cases and the left renal artery in 16. In the first patients, 2 bifurcated Dacron grafts were used for retrograde visceral grafting. After tunneling one graft through the loose retropancreatic tissue, the anastomosis to the celiac trunk was done in an end-to-side version to maintain splenic blood supply; each other visceral artery was anastomosed in an end-to-end version to the graft branches (8 patients). In the latter patients, a trifurcated Dacron graft was used, and except for one renal artery and the celiac artery, all visceral arteries were grafted in an end-to-end version to the graft. The renal artery was anastomosed in an end-to-side version into one of the graft branches (7 patients). In case three visceral arteries had to be grafted, a bifurcation prosthesis was combined with a Dacron graft (4 patients). If two visceral arteries had to be grafted, one bifurcation graft was used (1 patient). In all cases, the disconnected visceral arteries were ligated close to the aortic origin to prevent Type II endoleak. The immediate graft patency after revascularization was evaluated by flow measurement. All procedures were performed as single-step procedures with endovascular aortic repair after visceral/renal debranching.
After completing visceral and renal bypassing, a suitable access point was chosen for endovascular stent deployment. The stent was placed either through a femoral approach (8 patients) or through a conduit (12 patients) attached to the body of the retrograde graft (8 mm Dacron).To achieve optimal proximal stent positioning and to avoid proximal stent dislocation, the proximal stent was deployed under drug-induced cardiac arrest with adenosine (1 mg/kg body weight). In the case of a significant diameter difference between the proximal and distal attachment sites, the stent grafts were applied in reversed trombone technique starting in the distal attachment site (17 patients), in which case tapered stent grafts were used. A variety of stent grafts were used: in 15 patients, we used Talent® stent grafts (Medtronic, Santa Rosa, CA, USA); in 2 patients, Zenith® (Cook, Bloomington, IN, USA); and in 2 patients, Endofit® (LeMaitre Vascular, Burlington, MA, USA). On average, three (median) stent grafts were used (range 0-6 stent grafts) to exclude the TAAA. The proximal attachment site was distal the brachiocephalic trunk (zone 2) in 3 patients, distal the left common carotid artery (zone 3) in 1 patient, and distal the left subclavian artery (zone 4) in 15 patients. The procedures were completed by angiography to ensure graft patency as well as the absence of endoleaks (Table III).
Table III. Operative details of the conventional part (Conv.), the endovascular part (EV), the revascularized vessels (Revasc.), and postoperative complications for 20 patients after hybrid procedure
| Conv. | Revasc. | EV | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | IRAA | LRA | RRA | SMA | CT | Access SG | Prox. L.Z. | Prox. Debr. | Type of SG | No. of SG | OR time (min) | Postoperative complications |
| 1 | Yes | Yes | Yes | Yes | Yes | Conduit | 4 | No | Talent | 3 | 485 | Hematoma right kidney |
| 2 | No | No | No | Yes | Yes | Conduit | 4 | No | Talent | 3 | 250 | |
| 3 | Yes | Yes | Yes | Yes | Yes | Groin | 4 | No | Talent | 2 | 580 | Ischemic colitis |
| Necrotizing pancreatitis | ||||||||||||
| Multiorgan failure | ||||||||||||
| 4 | No | Yes | Yes | Yes | No | Groin | 4 | No | Talent | 3 | 454 | |
| 5 | No | Yes | Yes | Yes | Yes | Groin | 4 | No | Talent | 3 | 640 | |
| 6 | No | No | No | Yes | No | Conduit | 4 | No | Zenith | 1 | 445 | Pneumonia |
| 7 | No | Yes | Yes | Yes | Yes | Groin | 4 | No | Talent | 3 | 448 | |
| 8 | No | Yes | Yes | Yes | Yes | Conduit | 4 | No | Talent | 3 | 576 | |
| 9 | No | No | Yes | Yes | Yes | Conduit | 4 | No | Talent | 3 | 419 | Duodenal ulcer |
| 10 | No | X | Yes | Yes | Yes | Conduit | 2 | Yes | Talent | 4 | 555 | Global respiratory insufficiency |
| Incomplete paraplegia | ||||||||||||
| 11 | Yes | Yes | Yes | Yes | Yes | Groin | 4 | No | Talent | 2 | 464 | |
| 12 | Yes | Yes | Yes | Yes | Yes | Conduit | 4 | No | Talent | 2 | 468 | |
| 13 | No | Yes | Yes | Yes | Yes | Conduit | No | No | No | 0 | 600 | Severe bleeding from lumbar artery |
| 14 | Yes | Yes | Yes | Yes | Yes | Conduit | 4 | No | Endofit | 2 | 475 | |
| 15 | No | Yes | Yes | Yes | Yes | Conduit | 4 | No | Talent | 1 | 596 | |
| 16 | No | Yes | Yes | Yes | Yes | Conduit | 4 | No | Talent | 2 | 304 | Incomplete paraplegia |
| 17 | Yes | Yes | Yes | Yes | Yes | Conduit | 2 | Yes | Talent | 3 | 538 | Necrotizing pancreatitis |
| 18 | No | No | Yes | Yes | Yes | Groin | 4 | No | Endofit | 3 | 392 | Retroperitoneal infection |
| 19 | No | Yes | Yes | Yes | Yes | Groin | 2 | Yes | Talent | 4 | 365 | |
| 20 | Yes | Yes | Yes | Yes | No | Groin | 3 | Yes | Zenith | 6 | 935 | Necrotizing pancreatitis |
Follow-up
Follow-up was performed clinically and by CT scan and duplex scans postoperatively and every 6 months after initial surgery.
Results
The median hospital stay was 21.3 days (range 11-68 days), and the median intensive care unit stay was 8.1 days (range 2-19.1 days). The median procedure time was 499 minutes (range 250-935 minutes). Median blood loss was 1.9 L (range 0.5-7.0 L).
Technical Success
The procedure was completed in 19 of the 20 patients. In 1 patient, stent graft deployment was not completed because of impossible deployment in the aortic arch. This patient was rescheduled for stent grafting with a low-profile system due to aneurysm progression. He died on day 353 after visceral debranching, 5 days before readmission, from aneurysm rupture.
The 30-Day Mortality
The 30-day mortality was 5.5% (1 patient) in elective patients and 10% (2 patients) for the entire series. Patient 3 died on day 15 due to multiple system organ failure following colon ischemia and necrotizing pancreatitis. Patient 20 died on day 15 due to multiple system organ failure after the repair of a ruptured TAAA with a hemothorax.
Morbidity
Paraplegia/paraparesisPermanent paraparesis rate was 10% (2 patients). Both patients had incomplete paresis of the lower extremity. Patient 10 felt weakness in his legs but was able to walk without support. Patient 16 developed complete paralysis of the left leg and weakness of the right leg. Patient 12 showed delayed, transient neurological deficit with complete paraplegia lasting 12 hours, from which the patient recovered from completely (Table III).
Other major complicationsMajor complications included resection of an ischemic left colon in 1 patient, tracheostomy and prolonged respiratory support in 3 patients, temporary support for renal impairment in 3 patients, temporary inotropic support in 9 patients, and necrotizing pancreatitis in 2 patients.
Endoleak and Graft Patency
Postoperative multislice CT scan revealed six endoleaks in 5 patients (Type Ia, 3 patients; Type Ib, 1; Type II, 1; Type III, 1) and four visceral graft occlusions in 4 patients (right renal artery, 2 patients; left renal artery, 2). Except for one Type Ia endoleak, all Type Ia, Type Ib, and Type III endoleaks were surgically corrected. The occlusions of the renal grafts did not result in renal failure but rather in compensated and reversible elevation of the serum creatinine level (Table IV).
Table IV. Endoleaks and graft occlusions for 20 patients after hybrid procedure detected by postoperative multislice CT scan
| Patient | Type of endoleak | Consequence | Graft patency |
|---|---|---|---|
| 1 | Proximal I | Proximal debranching and proximal stent extension | AGP |
| 2 | III | AGP | |
| 3 | Occlusion right renal graft | ||
| 4 | AGP | ||
| 5 | III | Conservative | AGP |
| 6 | AGP | ||
| 7 | AGP | ||
| 8 | AGP | ||
| 9 | Proximal I | Conservative | AGP |
| 10 | AGP | ||
| 11 | AGP | ||
| 12 | AGP | ||
| 13 | Not stented | AGP | |
| 14 | AGP | ||
| 15 | Occlusion left renal artery | ||
| 16 | Proximal/distal I | Graft from ascending aorta to all supra-aortic branches and proximal/distal stent graft extension | Occlusion left renal artery |
| 17 | Occlusion right renal graft | ||
| 18 | AGP | ||
| 19 | AGP | ||
| 20 | AGP |
Follow-up
Average follow-up time was 174.5 days (range 15-375 days). During follow-up, 3 patients died; one patient sustained an aneurysm-related death. In detail, patient 6 died on day 60 due to pneumonia, patient 13 died on day 353 due to rupture of his aneurysm, and patient 10 died on day 167 as a result of pulmonary insufficiency. All the other patients of the series recovered to full activity and without signs of organ failure. Patient 8 showed a secondary proximal endoleak due to distal stent dislocation, which could be treated by proximal stent extension after proximal debranching. Patient 2 developed a type 3 endoleak, which was treated by stent grafting. Follow-up CT scans revealed a shrinkage of the aneurysm in 9 of the 20 patients; in 5 of the 20 patients, the shrinkage was 10 mm or more compared to the postoperative CT scans (Table V).
Table V. Maximum aneurysm diameter preoperatively, during follow-up, and diameter difference (mm) measured by axial CT scan in the 20 patients of the series
| Patient | Follow-up (days) | Maximum diameter preoperative (mm) | Maximum diameter follow-up (mm) | Difference (mm) |
|---|---|---|---|---|
| 1 | 324 | 68 | 76 | 8 |
| 2 | 375 | 96 | 99 | 3 |
| 3 | 15 | 61 | 61 | 0 |
| 4 | 243 | 55 | 42 | −13 |
| 5 | 182 | 78 | 72 | −6 |
| 6 | 60 | 120 | 120 | 0 |
| 7 | 191 | 58 | 54 | −4 |
| 8 | 257 | 72 | 54 | −18 |
| 9 | 49 | 71 | 70 | −1 |
| 10 | 353 | 86 | 86 | 0 |
| 11 | 182 | 50 | 31 | −19 |
| 12 | 225 | 78 | 78 | 0 |
| 13 | 167 | 100 | 100 | 0 |
| 14 | 66 | 61 | 51 | −10 |
| 15 | 240 | 77 | 60 | −13 |
| 16 | 40 | 54 | 54 | 0 |
| 17 | 120 | 92 | 90 | −2 |
| 18 | 98 | 58 | 54 | −4 |
| 19 | 63 | 62 | 63 | 1 |
| 20 | 15 | 90 | 90 | 0 |
| Median (range) | 174.5 (15-375) | 71.5 (55-120) | 61 (42-120) |
Discussion
This report concerns our experience with a prospective series of 20 patients who underwent the hybrid procedure. Overall, 30-day mortality rate was 10% in all cases and 5.5% in nonruptured cases. This is less than the mortality rate published for open surgery by the national database4, 5, 6 and comparable to the results of specialized centers.7, 8 Our results are encouraging considering that the patient group was high risk for open surgery regarding serious comorbidity, previous aortic surgery, and aneurysm morphology. All these factors are known as independent risk factors regarding morbidity after open surgery of TAAA.11, 14, 15, 16
Our results underline the findings of Black et al.,5 who showed in a comparable publication a mortality rate of 10% in elective and urgent patients. In contrast to the working group of the St. Mary´s hospital5 and another working group in Cologne,6 whose patients had no paraplegia, the paraparesis rate in our series was 10%. Spinal drainage might have improved our results regarding paraplegia. Two of three patients in our series developed spinal cord ischemia in the state of low arterial blood pressure. As in the early postoperative state, low systolic blood pressure is known as a strong independent risk factor for paraplegia;34 a careful monitoring of a prompt correction of blood pressure is indicated.
After infrarenal aortic repair, the risk for spinal cord ischemia seems to be elevated.34 Surprisingly, none of our affected patients had infrarenal aortic repair, but in both patients with persistent and in the one patient with transient spinal cord ischemia, proximal debranching procedures were performed prior to hybrid procedure. Even as we could confirm the anterograde perfusion of the left vertebral artery by angiography in all cases, proximal debranching might alter the collateral blood flow of the left vertebral artery after proximal debranching and enhance spinal cord ischemia. All three patients with spinal cord ischemia had immediate correction of the blood pressure and steroid therapy.34, 35, 36
In contrast to open surgery, endoleaks are a matter of concern after hybrid procedure. In total, we found 8 endoleaks in 7 patients (35%). This is comparable to the endoleak rate of Black et al. Our endoleak rate for Type I was 20%. Because Type I endoleaks are known to preserve the rupture risk of TAAA, we treated all Type I endoleaks aggressively with success. These results are controversial to the findings of Tse et al.37 and Black et al.,5 where some of the Type I proximal endoleaks persisted after proximal stent extension and proximal debranching. A higher endoleak rate for proximal Type I endoleaks was potentially avoided by proximal debranching prior to the hybrid procedure.
In our series, we applied three stent grafts on average (Fig. 2). For that reason, a Type III endoleak may be a potential risk factor in this complex procedure. In our series, we had one Type III endoleak in a patient after the repair, or a Type I TAAA with three stents applied in reversed trombone technique between the first and the second stent graft. This could be treated successfully by repeat stent grafting (Fig. 3). The reversed trombone technique is an effective method for stent grafting in patients with a significant mismatch of the diameter of the proximal and distal attachment sites. We performed retrograde repair using tapered stent grafts in 15 of our patients. In the hybrid procedure, retrograde alloplastic visceral and renal bypassing is necessary. No data exist about the durability and safety of that feature. Some information is provided from a couple of case studies, where patency rates as high as 90%-95% at 36 months were reported.38, 39, 40

Fig. 2
A, B Anterior and posterior views of the preoperative reconstruction (multislice CT scan) of the aorta with a thoracoabdominal aneurysm Type II. C, D Postoperative reconstruction of the CT scan showing a sufficient revascularization of the celiac trunk, superior mesenteric artery, and both renal arteries by two bifurcated grafts originating from the iliac arteries. Exclusion of the thoracoabdominal aneurysm by three stent grafts. E, F Follow-up CT scan (243 days postoperatively) of the descending thoracic aorta with significant shrinkage of the aneurysm sack compared to the CT scan 5 days after the procedure.

Fig. 3
A, B Type III endoleak between the first and second stent grafts in patient 2. C, D Exclusion of type III endoleak between the first and second stent grafts by repeat stent grafting (patient 2).
We tried to achieve revascularization of the superior mesenteric artery and celiac trunk in all cases because patients with isolated bypassing of the superior mesenteric artery are at unknown and unnecessary risk for severe visceral ischemia in case of graft occlusion to the superior mesenteric artery. In that specific case, the patent graft to the celiac trunk might avoid fatal acute visceral ischemia.5 In any case, revascularization of the celiac trunk in 2 patients could not be achieved due to severe obesity (body mass index >29 kg/m2). Furthermore, we had early graft occlusions in 4 patients: 2 grafts to the right renal artery and 2 grafts to the left renal artery occluded within 36 hours after the procedure. As there were no signs of worsening of the renal function, patients were treated conservatively. During follow-up, all grafts remained patent. The durability of the stent grafts, especially when several stents are applied, is still unclear. In our follow-up, 2 of 20 patients showed secondary endoleaks, which were, however, treated successfully. Regarding our median follow-up time of 174.5 days, a significant shrinkage of the aneurysm was found in 5 of the 20 patients.
Conclusion
Our results show that hybrid procedure might be an alternative to the conventional thoracoabdominal replacement of the aorta, especially in high-risk patients. Nevertheless, relevant mortality and morbidity rates are still present due to the extent of the procedure and the risk profile of the patients. Further studies are necessary to more precisely define morphological and clinical criteria that qualify patients for hybrid procedure, rather than for conventional repair. As long-term results are anticipated, the conventional thoracoabdominal repair of TAAA remains the gold standard.
References
- . Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vasc Surg. 1986;3:578–582
- Natural history of descending thoracic and thoracoabdominal aneurysms. Ann Thorac Surg. 1999;67:1927–1930discussion 1953-1928
- . Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg. 2003;37:1169–1174
- The outcome in the United States after thoracoabdominal aortic aneurysm repair, renal artery bypass, and mesenteric revascularization. J Vasc Surg. 2001;34:54–61
- . Complex thoracoabdominal aortic aneurysms: endovascular exclusion with visceral revascularization. J Vasc Surg. 2006;43:1081–1089discussion 1089
- . Hybrid-procedures for the treatment of thoracoabdominal aortic aneurysms and dissections. Eur J Vasc Endovasc Surg. 2007;33:71–77
- Descending thoracic aortic aneurysm repair: 12-year experience using distal aortic perfusion and cerebrospinal fluid drainage. Ann Thorac Surg. 2005;80:1290–1296discussion 1296
- . Thoracoabdominal aneurysm repair: results with 337 operations performed over a 15-year interval. Ann Surg. 2002;236:471–479discussion 479
- . Assessment of spinal cord integrity during thoracoabdominal aortic aneurysm repair. Ann Thorac Surg. 2002;74:S1864–S1866discussion S1892-S1868
- Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis. Ann Thorac Surg. 2000;69:409–414
- . Morbidity and mortality after extent II thoracoabdominal aortic aneurysm repair. Ann Thorac Surg. 2002;73:1107–1115discussion 1115-1106
- . Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2007;83:S862–S864discussion S890-S862
- Surgical repair of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (Torino). 2007;48:49–58
- . Surgical repair of thoracoabdominal aortic aneurysm: 10 years' experience. Br J Surg. 1995;82:624–629
- . Thoracoabdominal aneurysm repair: a representative experience. J Vasc Surg. 1992;15:780–787discussion 787-788
- . Renal dysfunction and prolonged visceral ischaemia increase mortality rate after suprarenal aneurysm repair. Br J Surg. 2003;90:1142–1146
- Combined endovascular and surgical approach (hybrid treatment) for management of type IV thoracoabdominal aneurysm. Vascular. 2005;13:124–128
- . Two-stage combined endovascular and surgical approach for recurrent thoracoabdominal aortic aneurysm. J Endovasc Ther. 2004;11:330–333
- . Ten years experience of thoracic and thoracoabdominal aortic aneurysm surgical repair: lessons learned. Ann Vasc Surg. 2004;18:514–520
- Retrograde visceral vessel revascularization followed by endovascular aneurysm exclusion as an alternative to open surgical repair of thoracoabdominal aortic aneurysm. J Vasc Surg. 2004;39:454–458
- Hybrid approaches to thoracic aortic aneurysms: the role of endovascular elephant trunk completion. Circulation. 2005;112:2619–2626
- Endovascular exclusion of a thoracoabdominal aortic aneurysm after retrograde visceral artery revascularization. Tex Heart Inst J. 2005;32:416–420
- . Iliorenal artery bypass grafting to facilitate endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2003;38:183–185
- . Repair of type IV thoracoabdominal aneurysm with a combined endovascular and surgical approach. J Vasc Surg. 1999;30:555–560
- Endovascular repair of thoracoabdominal aortic aneurysm with multivisceral revascularization. J Vasc Surg. 2005;42:368
- Combined open and endovascular treatment of complex aortic disease. Vascular. 2004;12:93–98
- . Endovascular stent-grafting for thoracoabdominal aortic aneurysm following bypass grafting to superior mesenteric and celiac arteries: report of two cases. Ann Thorac Cardiovasc Surg. 2005;11:335–338
- . Endovascular stent-graft repair for thoracoabdominal aneurysm after reconstruction of the superior mesenteric and celiac arteries. J Thorac Cardiovasc Surg. 2003;125:956–958
- Successful endografting with simultaneous visceral artery bypass grafting for severely calcified thoracoabdominal aortic aneurysm. J Vasc Surg. 2002;35:397–399
- . Endovascular repair of recurrent thoracoabdominal aortic aneurysm. J Endovasc Ther. 2002;9(suppl 2):II-106–II-111
- . Combined endovascular stent-graft repair and adjunctive visceral vessel reconstruction for complex thoracoabdominal aortic aneurysms. Int Angiol. 2007;26:213–218
- . Hybrid repair of an aortic arch aneurysm with complex anatomy: right aortic arch and anomalous origin of supra-aortic vessels. J Vasc Surg. 2007;46:128–130
- Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg. 1986;3:389–404
- . Spinal cord ischemia after elective stent-graft repair of the thoracic aorta. J Vasc Surg. 2005;42:11–17
- . Observations on delayed neurologic deficit after thoracoabdominal aortic aneurysm repair. J Vasc Surg. 1997;26:616–622
- Guidelines for the management of acute cervical spine and spinal cord injuries. Clin Neurosurg. 2002;49:407–498
- . The proximal landing zone in endovascular repair of the thoracic aorta. Ann Vasc Surg. 2004;18:178–185
- . Current results of surgical therapy for chronic mesenteric ischemia. Arch Surg. 1997;132:613–618discussion 618-619
- Mesenteric artery bypass: objective patency determination. J Vasc Surg. 1995;21:729–740discussion 740-721
- . Chronic mesenteric ischemia-surgical and interventional options in therapy. Chir Gastroenterol. 2006;22:36–41
PII: S0890-5096(09)00321-5
doi:10.1016/j.avsg.2009.10.010
© 2009 Annals of Vascular Surgery Inc. Published by Elsevier Inc All rights reserved.

